medical breakthrough

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

1 min read

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin-Angiotensin System, today...

Read More

FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus

4 min read

FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus

Today, the U.S. Food and Drug Administration approved Ixchiq, the first chikungunya vaccine. Ixchiq is approved for individuals...

Read More

The World’s First “Recombinant Anthrax Vaccine”: GC Biopharma applies for MFDS Approval

2 min read

The World’s First “Recombinant Anthrax Vaccine”: GC Biopharma applies for MFDS Approval

GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of “GC1109”, an anthrax vaccine...

Read More

First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations

2 min read

First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from an open-label, multicenter...

Read More

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

2 min read

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

Amgen (NASDAQ:AMGN) today announced data from the global Phase 3 CodeBreaK 300 trial evaluating two doses of LUMAKRAS® (sotorasib)...

Read More

Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1

3 min read

Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called...

Read More

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) application for VNT-101, a novel direct-acting antiviral against Influenza A virus

2 min read

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) application for VNT-101, a novel direct-acting antiviral against Influenza A virus

Via Nova Therapeutics, Inc., a biotechnology company focused on discovering and developing therapeutics to treat viral infections...

Read More

Two-Month Study of Pig Kidney Xenotransplantation Gives New Hope to the Future of the Organ Supply

2 min read

Two-Month Study of Pig Kidney Xenotransplantation Gives New Hope to the Future of the Organ Supply

After 61 days of observation, NYU Langone Health doctors this month completed the longest-documented case of a...

Read More

Breakthrough Percutaneous transvenous mitral commissurotomy (PTMC) procedure brings relief to 79yr old patient’s breathing issues at Wockhardt Hospitals in Mumbai Central

1 min read

Breakthrough Percutaneous transvenous mitral commissurotomy (PTMC) procedure brings relief to 79yr old patient’s breathing issues at Wockhardt Hospitals in Mumbai Central

Navigating the complexities of elderly healthcare often calls for an inventive approach. Wockhardt Hospitals, Mumbai Central, exemplified...

Read More

Young Software Engineer’s Remarkable Recovery through Minimally Invasive Keyhole Surgery: BGS Gleneagles Global Hospital Sets a New Standard for Spinal Cord Tumor Treatment

3 min read

Young Software Engineer’s Remarkable Recovery through Minimally Invasive Keyhole Surgery: BGS Gleneagles Global Hospital Sets a New Standard for Spinal Cord Tumor Treatment

In a remarkable case at BGS Gleneagles Global Hospital, a young software engineer’s battle against a spinal...

Read More